Dr Deborah Lambie

Investment Analyst

Deborah joined Milford in early 2020 as an Investment Analyst covering Global Equities. Prior to joining Milford, Deborah was an Associate in the Investment Banking Team at Jarden where she worked on a number of Mergers and Acquisitions & Equity Capital Markets (ECM) transactions including the sale of Aegis, the sale of TRG Imaging, the purchase of Hellers, and a number of capital raises.

Prior to this, Deborah worked as a medical doctor at Capital & Coast District Health Board, and was Chair of the New Zealand Medical Association Doctors in Training Council. Deborah also has an interest in online education and co-founded LearnCoach with David Cameron in 2015, which is widely used by NCEA students.

Deborah holds a Bachelor of Medicine and Bachelor of Surgery, Bachelor of Medical Science (Honours), Master of Entrepreneurship (Distinction) and is a CFA Charterholder.

Related Articles

Stock Story

Stock Story: Uber

Dr Deborah Lambie,8 March 2024

Uber can be thought of as the largest transportation company in the world. It has been a pioneer in the

Read More

Month in a minute

Month in a Minute: December 2023

Dr Deborah Lambie,11 January 2024

A Fast Finish
Funds delivered strong performances in December, building on the positive November to finish the year with solid gains.

Read More

Month in a minute

Month in a Minute: June 2023

Dr Deborah Lambie,7 July 2023

Halfway to a soft landing
Inflation is falling whilst economic growth looks to be resilient, delivering what investors have termed

Read More

Market Updates

Is globalisation dead?

Dr Deborah Lambie,22 December 2022

Last week, Dr Morris Chang, founder of TSMC – the world’s largest contract manufacturer of semiconductor chips, said that he

Read More

Stock Story

Stock Story: WillScot Mobile Mini

Dr Deborah Lambie,6 December 2022

WillScot Mobile Mini (WSC) is the market leader in North American modular workplace solutions (around 50% market share) and portable

Read More

Market Updates Masterclass

Biopharma: bolstering protection for our bodies and our portfolios

Dr Deborah Lambie,29 June 2022

2022 has brought with it significant volatility in global share markets. This has been driven by a multitude of factors

Read More

End of content

No more pages to load

Subscribe to weekly insights from our investment experts

Invest Now

Quick Links

2024© Milford Australia Pty Limited | Privacy Policy • Financial Services Guide • Website Terms & Conditions• Product Disclosure Statements

Equity Trustees Limited (“Equity Trustees”) (ABN 46 004 031 298), AFSL 240975, is the responsible entity for the Milford Investment Funds. Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).

The information provided in this website is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Fund, you should consider the current product disclosure statement (PDS) and Target Market Determination (‘TMD’) of the Fund and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.